Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract]
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest	$ 2,265	$ 1,761
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	132	145
Stock compensation expense	21	16
Credit for loan and lease losses	212	(580)
(Credit) provision for credit losses on off-balance sheet credit exposures	(150)	127
Impairment charge for OREO	58	130
Net amortization of AFS investment securities	348	410
Net accretion on loans	(144)	(110)
Net gains on sales of OREO	18	(280)
Net gains on sales of investment securities	(367)	(187)
Income from bank owned life insurance	(467)	(126)
Changes in assets and liabilities:
Decrease in accrued interest receivable	(71)	397
Decrease in other assets	(477)	(600)
Decrease in accrued interest payable	529	544
Decrease in other liabilities	391	(104)
Net cash provided by operating activities	2,298	1,543
Cash flows from investing activities:
Proceeds from maturities, calls and paydowns of AFS investment securities	17,308	8,226
Proceeds from sales of AFS investment securities	10,022	18,698
Purchase of AFS investment securities	(1,277)	(2,884)
Net increase in loans	(31,967)	(4,762)
Additions to OREO	(91)	(173)
Purchase of premises and equipment	(155)	(69)
Proceeds from sales of OREO	461	648
Net cash provided by investing activities	(5,699)	19,684
Cash flows from financing activities:
Increase in demand and NOW accounts	8,684	857
Increase (decrease) in money market and savings accounts	2,873	(7,455)
Decrease in certificates of deposit	(118)	(3,541)
Repayments of long-term borrowings	(113)	(114)
Distributions to noncontrolling interest	(45)	(172)
Issuance of Treasury Stock	33	26
Redemption of preferred stock	(5,800)	0
Proceeds from Stock Options Exercised	29	0
Net cash used in financing activities	5,543	(10,399)
Net increase (decrease) in cash and cash equivalents	2,142	10,828
Cash and cash equivalents at the beginning of the period	25,420	30,790
Cash and cash equivalents at the end of the period	27,562	41,618
Supplemental Disclosure
Interest paid	1,194	1,027
Transfers to OREO	$ 107	$ 1,087